European Commission approves new contract for a potential COVID-19 vaccine with Novavax (NVAX)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. AAPL
4. CHYM
5. USO
6. QCOM
7. IRT
8. MSI
9. ASO
10. LAES

Go back to European Commission approves new contract for a potential COVID-19 vaccine with Novavax (NVAX)
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.85 -0.34 (3.34%)
Previous Close $10.19    52 Week High $9.23 
Open $10.02    52 Week Low $1.16 
Day High $10.24    P/E N/A 
Day Low $9.73    EPS $-0.30 
Volume 4,430,002